Valeant Pharmaceuticals North America Advertiser Profile


Valeant Pharmaceuticals North America
Pharmaceutical Company
400 Somerset Corporate Blvd., Bridgewater, NJ US 08807
(908) 927-1400
Valeant Pharmaceuticals North America is part of:

Valeant Pharmaceuticals North America is part of Bausch Health Companies Inc.. They spent under $100 million on advertising in digital, print, and national TV in the last year. They are currently not investing in any premium ad units, but advertised on over 50 different Media Properties in the last year across multiple Media formats. Valeant Pharmaceuticals North America launched and advertised 2 new products in the past twelve months.

We have 10 people on file in marketing roles at Valeant Pharmaceuticals North America, and 8 at their agencies.

Summary


Valeant Pharmaceuticals North America is part of Bausch Health Companies Inc.. They spent under $100 million on advertising in digital, print, and national TV in the last year. They are currently not investing in any premium ad units, but advertised on over 50 different Media Properties in the last year across multiple Media formats. Valeant Pharmaceuticals North America launched and advertised 2 new products in the past twelve months.

We have 10 people on file in marketing roles at Valeant Pharmaceuticals North America, and 8 at their agencies.

MediaRadar helps advertising sales and agency business development teams reach the key decision makers at brands. Our contacts database includes full names, email addresses, specialties, agency relationships and phone numbers, and we verify each contact every 90 days to ensure you have the most current information.

We have identified 18 decision makers for you to contact at Valeant Pharmaceuticals North America, including Executives, Strategists, Media Buyers and Agency contacts.


Stacey W.
Vice President of Marketing, Dermatology

Terence P.
Associate Planning Director

Michael F.
Director of Payer Marketing and Strategy

Key Contacts


MediaRadar helps advertising sales and agency business development teams reach the key decision makers at brands. Our contacts database includes full names, email addresses, specialties, agency relationships and phone numbers, and we verify each contact every 90 days to ensure you have the most current information.

We have identified 18 decision makers for you to contact at Valeant Pharmaceuticals North America, including Executives, Strategists, Media Buyers and Agency contacts.


Stacey W.
Vice President of Marketing, Dermatology

Terence P.
Associate Planning Director

Michael F.
Director of Payer Marketing and Strategy

MediaRadar captures creative run on the top websites, magazines and national television stations for over 3 million brands. Here are 3 recent advertisements placed by Valeant Pharmaceuticals North America and its subsidiaries.
Mobile
Mobile
Last ran on Practical Dermatology Online on 12/31/2018.
TV
TV
Last ran on Univision on 6/15/2018.
Print
Print
Last ran on Cutis in the 12/2018 issue.
Mobile
Mobile
Last ran on Practical Dermatology Online on 12/31/2018.
TV
TV
Last ran on Univision on 6/15/2018.
Print
Print
Last ran on Cutis in the 12/2018 issue.

Recent Ad Creative


MediaRadar captures creative run on the top websites, magazines and national television stations for over 3 million brands. Here are 3 recent advertisements placed by Valeant Pharmaceuticals North America and its subsidiaries.
Mobile
Mobile
Last ran on Practical Dermatology Online on 12/31/2018.
TV
TV
Last ran on Univision on 6/15/2018.
Print
Print
Last ran on Cutis in the 12/2018 issue.
Mobile
Mobile
Last ran on Practical Dermatology Online on 12/31/2018.
TV
TV
Last ran on Univision on 6/15/2018.
Print
Print
Last ran on Cutis in the 12/2018 issue.

MediaRadar calculates estimated spend for the digital, print and national television campaigns that we identify using proprietary algorithms based on medium and advertisement type.
Valeant Pharmaceuticals North America Advertising Spend:
UNDER $100 Million
Decreased Spending YoY

Media Spend


MediaRadar calculates estimated spend for the digital, print and national television campaigns that we identify using proprietary algorithms based on medium and advertisement type.
Valeant Pharmaceuticals North America Advertising Spend:
UNDER $100 Million
Decreased Spending YoY

MediaRadar tracks new product launches across the 3 million+ brands in our database, and classifies each campaign to a specific product line using our proprietary classification methodology, giving you a deeper understanding of how a brand is allocating its advertising budgets. In the last year, we identified 25,487 new product launches overall.
Valeant Pharmaceuticals North America campaigns first seen Apr 2018.
Valeant Pharmaceuticals North America launched campaigns supporting 2 new product lines in the last twelve months, including Bedoyecta.

New Product Launches


MediaRadar tracks new product launches across the 3 million+ brands in our database, and classifies each campaign to a specific product line using our proprietary classification methodology, giving you a deeper understanding of how a brand is allocating its advertising budgets. In the last year, we identified 25,487 new product launches overall.
Valeant Pharmaceuticals North America campaigns first seen Apr 2018.
Valeant Pharmaceuticals North America launched campaigns supporting 2 new product lines in the last twelve months, including Bedoyecta.